The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFutura Medical Share News (FUM)

Share Price Information for Futura Medical (FUM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 38.80
Bid: 38.80
Ask: 39.55
Change: 0.40 (1.04%)
Spread: 0.75 (1.933%)
Open: 38.65
High: 38.80
Low: 38.65
Prev. Close: 38.40
FUM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK TRADING UPDATE SUMMARY: Brickability Recovering Well From Pandemic

Tue, 04th Aug 2020 19:16

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Brickability Group PLC - London-based construction materials distributor - Activity increasing since June and most employees back at work. All sites open and operating. Revenue for 3 months ended June 30 GBP23.8 million, June revenue at 83% of prior year with trend continuing in July. Return to profit in May from April loss with June Ebitda GBP1.6 million. Net debt GBP1 million as at June 30, with cash balance GBP24 million and GBP25 million revolving credit facility undrawn. Has unused GBP5 million overdraft plus GBP5 million accordion available. "While it is still too early to predict the level and sustainability of market recovery the group remains confident in the underlying demand for UK housing," says Brickability. Acquisition strategy still "on track", "evaluating a number of value-creating opportunities.

----------

Futura Medical PLC - pharmaceutical company headquartered in Guildford - Completes initial laboratory and optimisation work on Dermasys cannabidiol gel. DermaSys is Futura's transdermal drug delivery technology. The gel, CBD100, is being developed as part of a joint venture agreement with CBDerma Technology Ltd. "As part of a robust formulation process using strict pharmaceutical development principles, Futura has carried out extensive Dermasys Cannabidiol formulation work and initial in vitro tests on human epidermis. The studies demonstrate highly efficient penetration of cannabidiol into and through the skin, superior to an established, marketed, comparator product," says Futura. While cannabidiol can be unstable with common excipients, CBD100 is specially formulated to minimise this and has shown "encouraging early stability work" which is expected to ensure the gel's potency is retained during its shelf life.

----------

Pensana Rare Earths PLC - operator of rare earths project in Angola - Reports final assay results from final 86 holes of 8,000 metres drill programme at Longonjo NdPr project, Angola. Programme in support of banakable deasibility study due mid-October. Pensana says results from the programme: "Confirm the continuity of the weathered zone mineralisation from surface and also outline a wide area of mineralisation in fresh rock immediately below the current pit design that could add an extra dimension to the project beyond the initial mine life." From the Weathered zone, results include 18 metres at 7.93% rare earth oxides including 1.50% neodymium - praseodymium oxide from surface. Fresh Rock results include 18 metres at 4.40% REO including 0.86% NdPr from 44 metres.

----------

Beeks Financial Cloud Group PLC - Glasgow-headquartered cloud computing and connectivity provider for financial markets - Makes good progress against strategic objectives in financial year ended June 30. Expects to post annual result in range of market expectations. Says Velocimetrics acquisition integration progressing well with all tier 1 institutional customer implementations continuing as planned. Impact of Covid-19 pandemic "relatively small" when it comes to overall Beeks trading. Board still confident in "ongoing success" of Beeks. Final results due mid September.

----------

Malvern International PLC - London-based learning and skills development - Closes loss-making Singapore operations. Agrees with Singapore regulatory education board that most existing students will be either taught to the end of their course or transferred to different institutions. Chair Mark Elliott: "It is obviously disappointing to close our activities in Singapore but the operations there have been loss making for some time and, now due to impact of Covid-19, we can't see Singapore turning a profit in the medium term. We believe the group's resources are therefore best focused around the group's strongest performing schools in the UK." SAA Global Education subsidiary set to post 2019 net loss of SGD1.34 million, about GBP748,000, on revenue of SGD3.1 million. Manchester and London schools set to open August 10, Brighton school September. Bookings begin and university pathway bookings as expected.

----------

Open Orphan PLC - pharmaceutical services company headquartered in London - Signs new contract with Japanese firm Carna Bioscience for a first in human clinical pharmacology trial. Carna specialises in kinase biology, developing cancer and immune disorder treatments. The new contract builds on "several years" worth of existing work wherein both parties collaborated closely on drug development planning as well as pre-clinical activities. The contract is forecast to generate "significant revenue" for Open Orphan's Venn Life Sciences business in the next 12 months. Venn has also been awarded a contract extension to continue a Dutch biotech on chemistry, manufacturing and controls until the end of the year at least.

----------

Physiomics PLC - oncology drug development consultancy with headquarters in Oxford - Confirms trading in line with analyst expectations for financial year ended June 2020. Financial 2021 starts well with further Bicycle Therapeutics contract announced June and "strong continuing relationship with Merck KGaA". Experiences increased introductory call volumes with potential new clients due to marketing investment. Cash June end GBP1.1 million following GBP830,000 placing announced May. Set to publish final results in week commending September 28.

----------

Genedrive PLC - Manchester-based molecular diagnostics firm - Enters collaboration with Beckman Coulter Life Sciences to fully automate the laboratory PCR testing process for Covid-19. PCR tests are used to determine if a patient currently has the virus. The companies are working on combining and validating the Genedrive 96 SARS-CoV-2 Kit on the Biomek i7 automated workstation with saliva samples extracted using Beckman Coulter's RNAdvance viral extraction chemistry.

----------

Serabi Gold - Brazilian focused gold mining and development company - Agrees to extend dawdown period on USD12 million convertible loan facility with Greenstone Resources II LP by six months to June 2021. Chief Executive Hodgson: "Extending, by six months, the period in which we can draw down on the convertible, will relieve pressure to draw down funds earlier than might otherwise be necessary and avoid incurring additional debt under the convertible that may ultimately not be required. This is excellent news for the company and its shareholders."

----------

Reabold Resources PLC - London-based oil and gas projects investor - Notes "significant progress" at West Newton B site in Yorkshire with initial drilling operations set to begin in the next few weeks. "The B-1 well has the dual objective of appraising the significant discovery made in the Kirkham Abbey formation, as well as evaluating the deeper and potentially substantial Cadeby formation in a more optimal location than was encountered at the A-2 well," according to Reabold. Says a combined testing programme at West Newton B-1 and A-2 will follow on from B-1 drilling.

----------

Union Jack Oil PLC - UK focused onshore hydrocarbon production, development and exploration company - Notes West Newton update. Holds 17% interest in PEDL183 containing West Newton B-1 appraisal well and West Newton A-2 discovery well.

----------

Kazera Global PLC - Cardiff-headquartered AIM quoted investment company - Completes drilling portion of phase 2 exploration programme with a preliminary study of phase 2 cores continuing to identify the presence of lithium and tantalite mineralisation in the pegmatite intermediate zone. Homestead, Purple Haze, Snake and Signaalberg surpass expectations with 95% average pegmatite intersect for holes drilled. Preparing to ship approximately 300 drill core samples for assay and reporting by 2020 end. Completes testing on channel samples, demonstrating grade of estavblished resouces ongoing at White cut. Explores options for phase 3 programme to test virgin groun. In advanced talks with new mine operator with over 30 years' experience as Namibia-based company. Orange River pipeline project progresses, government compliancy certificates complete and in positive talks with Namibian investor.

----------

Blencowe Resources PLC - operator of Ugandan graphite project - Says additional metallurgical test work will shortly begin at Orom-Cross graphite project in northern Uganda. This test work is "critical to understanding the quality of the end-product that Orom-Cross can deliver as a high grade graphite concentrate, as well as what the process flow will look like to achieve this." A 69-hole, 1,950 metres diamond drilling programme has completed at Orom-Cross, intended to deliver a maiden JORC resource. The drilling and test work both form integral parts of the projects's development and are necessary to complete a feasibility study later in 2020. Appoints SGS Lakefield (Canada) to conduct additional metallurgical assessment after previous metallurgy partner Metzana's closure.

----------

Pelatro PLC - London-based telecom customer engagement software - Announces GBP2.1 million placing and subscription through conditional issue of 4.5 million shares at 47 pence each. Fundraise arranged by Cenkos Securities. Issue price a 12% premium to Monday closing price. Net proceeds to be used to strengthen sales team, for marketing at conferences, and for Managed Servives working capital. Shareholder approval required at August 20 general meeting.

----------

Water Intelligence PLC - London-headquartered leak detection and remediation solutions - Reacquires franchise operation in Melbourne, Australia within American Leak Detection subsidiary. For trailing 12 months, including 6 of Covid-impacted results, Melourne operation generates USD1.3 million in sales plus AUD270,000 in profit. Purchase price AUD1.8 million. "Melbourne is a significant reacquisition because it complements the group's other corporate base in Sydney," says Water Intelligence.

----------

Immotion Group PLC - Manchester-based immersive entertainment group - 'Ocean Explorer Virtual Reality Theater', the company's largest installation to date, opens August 1 in Shark Reef Aquarium at Mandalay Bay Resort & Casino. Ocean Explorer is a 36-seat virtual reality theatre and will charge USD9 per guest, included in the standard aquarium ticket package. Acquarium currently welcoming around 1,000 visitors a day, historically has seen over 500,000 visitors a year.

----------

Active Energy Group PLC - London-headquartered biomass-based renewable energy business - Is granted construction and air permit for CoalSwitch plant at Lumberton, North Carolina. Permit granted by North Carolina Division of Air Quality and allows Active Energy to begin the final stage planning and construction of CoalSwitch, with a targeted production capacity of up to 5 tonnes per hour.

----------

Edenville Energy PLC - operator of Rukwa coal project in Tanzania - Confirms recommencement of operations at Rukwa on Monday. Minimal mine area damage during protracted rainy season, which finishes while mine was closed amid pandemic. First shipment of coal from restart expected early nect weekm subject to truck availability.

----------

Advanced Medical Solutions Group PLC - wound care specialist company with headquarters in Cheshire - Is granted UK and US patents for its LiquiBand Exceed range, giving patent protection through to 2034. UK patent gives further tax benefit through UK patent boz scheme, shrinking effective tax rate by between 1% an 2% over patent life.

----------

Applied Graphene Materials PLC - graphene materials maker with headquarters in Redcar, Cleveland - Inks distribution agreement with Belgian-headquartered chemical distributor Arpadis Benelux NV. Agreement strengthens Applied Graphene supply position in "many of Europe's largest coatings and polymers markets, providing direct routes into these market sectors". Companies will work to collaborate on customer opportunities, introduce Genable graphene dispersions technology into the United Kingdom, Germany, Spain, France, Portugal and Scandinavia coatings and polymers markets.

----------

Tiziana Life Sciences PLC - London-headquartered biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases - Unveils expediated clinical development plan for TZLS-501, its novel fully human anti-interleukin-6 receptor monoclonal antibody, as a treatment for Covid-19. A clinical study is set to begin in the first quarter of 2021.

----------

Reach4Entertainment Enterprises PLC - London-headquartered marketing group in the live performance and entertainment markets - Intends to cancel admission of shares to trading on AIM and re-register as a private company. Given the Covid-19 pandemic's damage to its business, thanks to the closure of all live venues on Boradway and London's West End, Reach4Entertainment feels that "the costs of maintaining a London listing outweigh the benefits afforded by operating as a public company".

----------

Directa Plus PLC - Wiltshire-based producer and supplier of graphene nanoplatelets based products - Notes Monday opening of new Genoa San Giorgio Bridge in Italy. Bridge pavement constructed using Gipave asphalt supermodifier, developed by Iterchimica with the support of Directa Plus.

----------

BMO Commercial Property Trust Ltd - London-based investment company - Net asset total return negative 2.9% for three months ended June 30 and share price total return negative 15% for quarter. Second quarter rent collection 83%, third quarter collection to date 68%. Cash available June 30 GBP23 million and undrawn revolving credit facility GBP50 million. Comfortably meeting covenants on GBP260 million long-term loan.

----------

Ariana Resources PLC - gold exploration and development company with joint venture gold mining operations in Turkey - Signs revised agreement with Kefi Minerals PLC for net smelter return on Kizilcukur project in Turkey. Final agreement cancels 2% net smelter return on Kizilcukur and scraps previously envisaged acquisition of Kefi subsidiary Dogu Akdeniz Mineralleri San ve Tic Ltd. Kefi's Turkey exploration database will transfer to Arana and the total cash consideration will be GBP75,000, with GBP15,000 already paid. Ariana to acquire 2.5% net smelter royalty on Koza Altin Isletmeleri AS's Yatik project after paying another GBP75,000 to Kefi. Should mining begin at Yatik, 50% of royalty payments made by Koza to Ariana will be paid by Ariana to Kefi.

----------

Pembroke VCT PLC - London-headquartered venture capital trust - Plans to launch subscription offer of new B shares for subscription in 2021 and 2022 tax years. Details to follow in September prospectus.

----------

By Anna Farley; annafarley@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
9 Aug 2023 12:07

IN BRIEF: Futura Medical's ED treatment approved in Saudi Arabia

Futura Medical PLC - Surrey, England-based pharmaceutical company - Says its distribution partner, Labatec Pharma, received regulatory approval for MED3000 in Saudi Arabia. MED3000 is Futura's topical, gel-based erectile dysfunction treatment. Labatec will exclusively launch and commercialise MED3000 under the brand name Eroxon, with initial launch planned in the final quarter of 2023. Adds the manufacturing of Eroxon for launch has been completed.

Read more
18 Jul 2023 14:16

Futura Medical chair steps down, promotes non-executive director

(Alliance News) - Futura Medical PLC on Tuesday said it appointed Non-Executive Chair Jeff Needham as the successor to outgoing chair John Clarke, who has stepped down.

Read more
17 Jul 2023 09:13

Futura Medical agrees US licensing deal with Haleon for Med3000 gel

(Alliance News) - Futura Medical PLC on Monday said it agreed a licensing deal with Haleon PLC for the rights to exclusively commercialise Futura's erectile dysfunction treatment Med3000 in the US.

Read more
17 Jul 2023 08:33

Futura Medical shares rise on ED licensing deal with Haleon

(Sharecast News) - Shares in Futura Medical gained on Monday after the company said it signed a licensing deal with consumer heath care giant Haleon for the rights to exclusively commercialise its topical, gel-based erectile dysfunction treatment MED3000 in the USA.

Read more
22 Jun 2023 14:45

IN BRIEF: Futura Medical hails continued momentum after Eroxon launch

Futura Medical PLC - Guildford, Surrey-based pharmaceutical company - Says it is encouraged by the early growth trajectory of erectile dysfunction treatment gel Eroxon following its recent launch. "Both initial orders of Eroxon by our partners and in-market demand have been in line with our expectations and should continue to build as partners expand sales channels, numbers of outlets and new geographies," it adds. Predicts that net revenue for the six months ending June 30 will be no less than GBP1.5 million. Says momentum continues to build as it enters the commercialisation phase and positions itself to receive its first significant revenue in 2023. It previously in April said that its 2022 pretax loss widened to GBP6.9 million from GBP5.8 million the year before.

Read more
15 Jun 2023 15:51

UK shareholder meetings calendar - next 7 days

Friday 16 June 
Alpha Growth PLCAGM
Anglo-Eastern Plantations PLCAGM
Gulf Keystone Petroleum LtdAGM
John Lewis of Hungerford PLCGM re proposed cancellation of admission to trading on AIM
Tesco PLCAGM
Woodbois LtdAGM
Monday 19 June 
All ThingsConsidered Group PLCAGM
Blackbird PLCAGM
Finsbury Food Group PLCAGM
Globalworth Real Estate Investments LtdAGM
Marlowe PLCGM re proposed capital reduction
Metals Exploration PLCAGM
Red Rock Resources PLCGM re security conversion into shares for cash
Savannah Resources PLCAGM
Tuesday 20 June 
Acceler8 Ventures PLCAGM
Afentra PLCAGM
Armadale Capital PLCAGM
Bay Capital PLCAGM
Blackrock Smaller Companies Trust PLCAGM
Block Energy PLCAGM
Corero Network Security PLCAGM
Coro Energy PLCAGM
Crimson Tide PLCAGM
Curtis Banks Group PLCAGM
EPE Special Opportunities LtdAGM
ICG-Longbow Senior Secured UK Property Debt Investments LtdAGM
Jersey Oil & Gas PLCAGM
Kore Potash PLCAGM
Lords Group Trading PLCAGM
Mission Group PLCAGM
North Atlantic Smaller Cos Investment Trust PLCAGM
Red Capital PLCAGM
Saga PLCAGM
SDX Energy PLCAGM
Skillcast Group PLCAGM
Zegona Communications PLCAGM
Wednesday 21 June 
Argentex Group PLCAGM
Clean Power Hydrogen PLCAGM
Eqtec PLCAGM
Hydrogen Utopia International PLCAGM
HSS Hire Group PLCAGM
Intelligent Ultrasound Group PLCAGM
JD.com IncAGM
RTW Venture Fund LtdAGM
Schroders Capital Global Innovation Trust PLCAGM
Sivota PLCAGM
Numis Corp PLCGM re acquisition by Deuche Bank AG
THG PLCAGM
UK Commercial Property REIT LtdAGM
Thursday 22 June 
Alphawave IP Group PLCAGM
Angling Direct PLCAGM
Anglo Asian Mining PLCAGM
boohoo Group PLCAGM
Card Factory PLCAGM
Ergomed PLCAGM
Futura Medical PLCAGM
Good Energy Group PLCAGM
Grand Vision Media Holdings PLCAGM
Longboat Energy PLCAGM
MaxRets Ventures PLCAGM
Pathfinder Minerals PLCAGM
RBG Holdings PLCAGM
Sanderson Design Group PLCAGM
Team17 Group PLCAGM
Trellus Health PLCAGM
Whitbread PLCAGM

 

Read more
12 Jun 2023 12:08

LONDON MARKET MIDDAY: Stocks firm as expected Fed pause still in doubt

(Alliance News) - Stock prices in London were tentatively higher at midday on Monday, as investors looked ahead to a key US inflation print on Tuesday with some caution ahead of the Federal Reserve's next interest rate decision.

Read more
12 Jun 2023 10:13

AIM WINNERS & LOSERS: Ovoca Bio drops as Orenetide study delayed

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
12 Jun 2023 09:47

Futura shares jump after FDA approval for erectile dysfunction product

(Alliance News) - Futura Medical PLC said on Monday that the US Food & Drug Administration granted over the counter sale marketing authorising for MED3000, the company's treatment of erectile dysfunction.

Read more
18 Apr 2023 13:09

Futura's erection gel launched over-the-counter in the UK

(Sharecast News) - Sexual health-focussed pharmaceutical company Futura Medical announced on Tuesday that its topical gel formulation for the treatment of erectile dysfunction (ED), MED3000, is now available in the UK under the 'Eroxon' brand.

Read more
18 Apr 2023 12:32

Futura launches Eroxon erectile dysfunction gel in UK stores

(Alliance News) - Futura Medical PLC announced on Tuesday that its erectile dysfunction treatment gel Eroxon is now available for purchase in the UK.

Read more
5 Apr 2023 12:21

Futura Medical annual loss widens as eyes MED3000 progress

(Alliance News) - Futura Medical PLC said on Wednesday its annual loss widened as it focused on the commercialisation of its new MED3000 product.

Read more
29 Mar 2023 15:48

UK earnings, trading statements calendar - next 7 days

Thursday 30 March 
AO World PLCTrading Statement
Aquis Exchange PLCFull Year Results
Arbuthnot Banking Group PLCFull Year Results
Ascential PLCFull Year Results
BBGI Global Infrastructure SAFull Year Results
Chesnara PLCFull Year Results
Ebiquity PLCFull Year Results
Gattaca PLCHalf Year Results
Gresham House PLCFull Year Results
IGas Energy PLCFull Year Results
Impellam Group PLCFull Year Results
International Public Partnerships LtdFull Year Results
Ithaca Energy PLCFull Year Results
Microlise Group PLCFull Year Results
Moonpig Group PLCTrading Statement
PetroTal CorpFull Year Results
Renalytix PLCHalf Year Results
Revolution Beauty Group PLCFull Year Results
Robinson PLCFull Year Results
Secure Trust Bank PLCFull Year Results
Supermarket Income REIT PLCHalf Year Results
XLMedia PLCFull Year Results
Friday 31 March 
Amaroq Minerals LtdFull Year Results
Bank of Cyprus Holdings PLCFull Year Results
Computacenter PLCFull Year Results
Cooks Coffee Co LtdFull Year Results
CT Private Equity Trust PLCFull Year Results
Dignity PLCFull Year Results
ECO Animal Health Group PLCTrading Statement
HealthBeacon PLCFull Year Results
Impax Environmental Markets PLCFull Year Results
James Halstead PLCHalf Year Results
Jaywing PLCTrading Statement
JPMorgan American Investment Trust PLCFull Year Results
Numis Corp PLCTrading Statement
Mothercare PLCTrading Statement
Quarto Group IncFull Year Results
UK Oil & Gas PLCFull Year Results
Vanquis Banking Group PLCFull Year Results
Monday 3 April 
Downing Renewables & Infrastructure Trust PLCFull Year Results
Elixirr International PLCFull Year Results
Fidelity Japan Trust PLCFull Year Results
Gaming Realms PLCFull Year Results
HydrogenOne Capital Growth PLCFull Year Results
N4 Pharma PLCFull Year Results
Renew Holdings PLCTrading Statement
Tracsis PLCHalf Year Results
Tuesday 4 April 
accesso Technology Group PLCFull Year Results
Anexo Group PLCTrading Statement
Epwin Group PLCFull Year Results
Merchants Trust PLCFull Year Results
Renewi PLCTrading Statement
Saga PLCFull Year Results
Wednesday 5 April 
EnQuest PLCFull Year Results
Futura Medical PLCFull Year Results
Hilton Food Group PLCFull Year Results
Lookers PLCFull Year Results
Lords Group Trading PLCFull Year Results
RS Group PLCTrading Statement
Topps Tiles PLCTrading Statement
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
29 Mar 2023 09:52

IN BRIEF: Futura responds to US FDA on erectile dysfunction treatment

Futura Medical PLC - Surrey, England-based sexual health-focused pharmaceutical company - Says it has submitted a full response to questions from the US Food & Drug Administration and confirmatory data regarding its MED3000 erectile dysfunction treatment. This is for the FDA to continue its review of the product. Notes that it expects the grant of the De Novo request in the second quarter of 2023. A De Novo classification by the FDA provides an alternate pathway to marketing approval for novel medical devices.

Read more
14 Mar 2023 14:33

Futura Medical confirms Europe launch of MED3000; awaits FDA approval

(Alliance News) - Futura Medical PLC on Tuesday said its MED3000 product is now available online in Europe under the brand name Erexon.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account